InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Nelsen Robert, Director. Officer active across 5 companies, notably Vir Biotechnology, Inc.. In total, 28 disclosures have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €29.2m. Activity tracked since 21 May 2021. The latest transaction was disclosed on 1 August 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Nelsen Robert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
3,030,300 shares@ US$3.3032.0% of flowCommon StockSEC:0001062993-25-013462:0
Canonical exit: 30 Oct 2025 (T+90)
8,000 shares0Common StockSEC:0001628280-24-026213:0
3,200,000 shares@ US$6.25100.0% of flowCommon StockSEC:0001062993-24-003740:0
Canonical exit: 15 May 2024 (T+90)
363,637 shares@ US$5.50100.0% of flowCommon StockSEC:0001062993-24-002842:0
Canonical exit: 8 May 2024 (T+90)
6,027 shares0Common StockSEC:0001209191-23-031882:0
536 shares0Common StockSEC:0001562180-23-000268:0
5,728,297 sharesCommon StockSEC:0001628280-22-027124:0
321 shares0Common StockSEC:0001562180-22-007110:0
196,003 shares0Common StockSEC:0001062993-22-019343:0
217,781 shares0Common StockSEC:0001062993-22-018985:0
217,781 shares0Common StockSEC:0001062993-22-018812:0
217,781 shares0Common StockSEC:0001062993-22-018574:0
217,781 shares0Common StockSEC:0001062993-22-018155:0
266 shares0Common StockSEC:0001562180-22-005622:0
217,781 shares0Common StockSEC:0001062993-22-014695:0
217,781 shares0Common StockSEC:0001062993-22-014427:0
6,405 shares0Common StockSEC:0001209191-22-031975:0
102,041 shares0Common StockSEC:0001062993-22-012007:0
230 shares0Common StockSEC:0001562180-22-003312:0
762,233 shares0Common StockSEC:0001062993-21-013386:0
217,781 shares0Common StockSEC:0001062993-21-011919:0
217,781 shares0Common StockSEC:0001062993-21-011644:0
1,742,248 shares0Common StockSEC:0001062993-21-006363:0
435,562 shares0Common StockSEC:0001062993-21-005943:0
18,206,358 sharesCommon StockSEC:0001209191-21-042801:0
25 of 28 declarations
About Nelsen Robert
NELSEN ROBERT is Administrateur and a declarant at Vir Biotechnology, Inc., Sana Biotechnology, Inc., Prime Medicine, Inc., Denali Therapeutics Inc., and Lyell Immunopharma, Inc. He has 28 filings in total, and in the 28 sampled filings, buys amount to EUR 29245314, with no sells, between 2021-05-25 and 2025-08-01.
